Effective as of September 14, 2023, Michael Dougherty retired as a member of the Board of Directors of Trevena, Inc., and as a member of the Audit Committee of the Board. Mr. Dougherty?s departure was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices. Mr. Dougherty has over 35 years of experience in the biopharmaceutical industry, and served on the Company?s Board of Directors since 2013 just prior to its initial public offering.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.391 USD | -4.40% | +11.08% | -45.85% |
Apr. 01 | Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 01 | Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.85% | 7.16M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- TRVN Stock
- News Trevena, Inc.
- Trevena, Inc. Announces Retirement of Michael Dougherty as A Member of the Board of Directors and as A Member of the Audit Committee, Effective as of September 14, 2023